Lygos, Sirrus announce synthesis of biobased methylene malonates

By Lygos Inc. | May 10, 2016

Lygos Inc. and Sirrus Inc. have jointly announced that Sirrus has successfully synthesized its Chemilian 1,1 di-substituted alkenes using Lygos' bio-DEM. This marks the first known synthesis and purification of this breakthrough class of monomers using biobased malonate esters at laboratory scale. The Sirrus class of monomers presents a broad range of unique properties for various industries that the company believes may drive large volume demand for bio-derived malonate esters.

"Our success in synthesizing methylene malonates from Lygos' renewable bio-DEM demonstrates our belief that a renewable supply chain will be valued by our partners and customers," said Sirrus CEO Jeff Uhrig. "We are excited about working with Lygos to build on this success with pilot scale testing that, if successful, could lead to renewable product introduction in 2017."

"We're pleased be working with an innovative company like Sirrus, which shares our vision of a future in which petrochemicals are replaced by green chemicals. We look forward to delivering more bio-DEM to Sirrus in the future," commented Lygos' CEO, Eric Steen.